News

Important Deadlines for Shareholders of SelectQuote and KinderCare

Important Deadlines for Shareholders of SelectQuote and KinderCare

Understanding Shareholder Deadlines

As various companies face shareholder class action lawsuits, it is crucial for investors to stay informed about key deadlines. Holzer & Holzer, LLC emphasizes the importance of acting swiftly to safeguard your rights as a shareholder. This article outlines significant deadlines for potential lead plaintiffs in lawsuits targeting SelectQuote, Unicycive Therapeutics, and KinderCare Learning Companies.

SelectQuote, Inc. (SLQT) Lawsuit

The shareholder class action lawsuit against SelectQuote, Inc. alleges that the company may have misled investors regarding its compliance with legal regulations, particularly concerning the False Claims Act. This class action pertains to claims made between September 9, 2020, and May 1, 2025. Investors who purchased shares during this timeframe and have experienced losses are encouraged to explore their legal options.

Know Your Rights

If you find yourself in this situation, it is essential to consult with legal professionals who specialize in shareholder rights. You can reach out to Corey D. Holzer, Esq. at Holzer & Holzer, LLC, who can provide more information on the class action lawsuit and how to participate. The deadline to request lead plaintiff status in this case is October 10, 2025.

Unicycive Therapeutics (UNCY) Class Action Details

The lawsuit against Unicycive Therapeutics contains allegations that the company failed to disclose crucial information regarding its ability to meet FDA manufacturing compliance standards. This lawsuit covers actions taken from March 29, 2024, through June 27, 2025. Shareholders who believe they have been affected are strongly encouraged to reach out for legal counsel.

Deadline for Engagement

To become a lead plaintiff in this lawsuit, it’s crucial to act before the deadline of October 14, 2025. Legal representation can help in navigating this process, ensuring your rights are protected as a shareholder.

KinderCare Learning Companies, Inc. (KLC)

KinderCare faces allegations in a class action lawsuit claiming misrepresentation concerning the quality of care provided at its facilities, particularly in relation to its October 2024 IPO. If you purchased shares of KinderCare during this period and suffered significant losses, it’s vital to seek legal advice.

Acting Quickly is Essential

The deadline for shareholders to engage in this case as lead plaintiffs also falls on October 14, 2025. Navigating the complexities of such lawsuits requires expert guidance, and Holzer & Holzer, LLC has a dedicated team to assist you.

About Holzer & Holzer, LLC

Established in 2000, Holzer & Holzer, LLC is noted for its commitment to the representation of shareholders and investors in litigation cases across the country. The firm has successfully recovered substantial amounts for individuals affected by corporate misconduct. For more information, visit their website or connect with their office regarding any questions or advice concerning these proceedings.

Frequently Asked Questions

What is a lead plaintiff in a class action lawsuit?

A lead plaintiff is the individual who represents all members of a class in a class action lawsuit. They are typically involved in major decisions throughout the case.

How do I know if I can participate in a class action lawsuit?

If you purchased shares within the specified time frames of the lawsuits and have faced losses, you may qualify to participate.

What steps should I take if I believe I am eligible?

Contact a law firm specializing in class action suits, like Holzer & Holzer, LLC, to discuss your eligibility and options.

Are there deadlines to be aware of?

Yes, each lawsuit has specific deadlines to request lead plaintiff status. Ensure you are informed about these timelines.

What should I expect if I join the lawsuit as a lead plaintiff?

You will likely have an active role in the litigation process and may need to provide information or testimony about your experience as a shareholder.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading

Top 5 Most Recently Viewed Articles

ACRES Commercial Realty Corp. Expands Share Buyback Program

Updated Category News Views 153

ACRES Commercial Realty Corp. Announces New Share Repurchase ACRES Commercial Realty Corp. (NYSE: ACR) has recently made headlines with its decision to reauthorize an additional $5 million for its existing share repurchase program. This strategic move by the Company’s board of directors reflects their commitment to enhancing shareholder value and signals confidence in...

Continue Reading
Crypto Market Analysis: Trader Alerts on August Local Top

Updated Category News Views 246

Crypto Trader Warns of Local Top in August A well-known pseudonymous trader, who previously identified the local bottom for major cryptocurrencies, is now predicting a potential local top as we approach August. This caution comes in light of the market’s current bullish momentum. Revisiting Past Predictions On July 18, this trader reiterated his earlier insights from...

Continue Reading
Amazon's Ambitious $5 Billion Export Plan to Shift Supply Chains

Updated Category News Views 51

Amazon's Export Strategy for 2024 Amazon Inc is setting its sights on ambitious growth for 2024, aiming to export around $5 billion worth of small-ticket items from India. This represents an increase from nearly $3 billion in 2023 and focuses on markets like the United States and Britain, indicating a significant shift away from traditional supply sources such as China....

Continue Reading
Kasa's Strategic Alliance with Mint House for Hospitality Growth

Updated Category News Views 124

Kasa and Mint House Unite for Industry Leadership Kasa, a leader in the hotel and apartment hotel sector, has announced an exciting strategic combination with Mint House, a brand renowned for premium residential hospitality. This partnership signifies a milestone in flexible accommodations, enriching the hospitality landscape for corporate and leisure travelers alike....

Continue Reading
GN Store Nord Annual Report 2024 Highlights Revenue Growth

Updated Category News Views 1113

2024 Financial Highlights of GN Store Nord Key Performance Summary GN Store Nord has announced its financial results for 2024, marking an impressive journey towards sustainable growth. The company recorded a total revenue of DKK 18.0 billion with a modest organic revenue growth of 1%. This growth was supported mainly by a remarkable 10% organic growth in the Hearing...

Continue Reading